The Business Development Board of Palm Beach County (BDB), in cooperation with Enterprise Florida, the Florida Department of Economic Opportunity, and the City of Boca Raton, is pleased to announce that Modernizing Medicine, a specialty-specific health information technology leader, plans to expand operations in the Boca Raton Innovation Center (BRIC) and that it will add 838 jobs by 2022. Modernizing Medicine anticipates making a capital investment of more than $15 million in the Boca Raton community.
Today, Governor Rick Scott announced that Modernizing Medicine plans to expand operations in the historic Boca Raton Innovation Center (BRIC) in Palm Beach County and will add a total of 838 jobs by 2022. Modernizing Medicine is a Florida based company that specializes in healthcare information technology. In addition to the more than 800 new jobs being created, Modernizing Medicine anticipates making a capital investment of more than $15 million in the Boca Raton community.
A South Florida teenager just might be on the verge of a groundbreaking development in cancer research. At just 14-years-old, he hopes his invention will be used to improve early detection and diagnosis of cancerous tumors.
MORE “Boca Raton teen’s invention could help improve early detection, diagnosis of cancer”
A group of eighth-grade Medical Science Academy students from Howell L. Watkins Middle School had unprecedented access and exposure to healthcare careers and patient care during an externship program at Good Samaritan Medical Center in West Palm Beach.
Nurse practitioners (NPs) can help meet the rising demand for health care due to older population growth, especially in underserved populations. They are highly skilled and educated clinicians dedicated to improving public health through a wide range of primary care services, providing a holistic approach that combines culture and community.
JUPITER, Fla., July 10, 2017 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), announced today that it has entered into a comprehensive series of research and development agreements, including a potential commercialization agreement, with Biotechnology Development for Industry (“BDI Holdings”), a Spanish biotech company, and its subsidiaries – VLP The Vaccines Company, S.L.U. (“VLPbio”), and Biotechnology Developments for Industry in Pharmaceuticals, S.L.U. (“BDI Pharma”) (collectively “BDI”). Dyadic expects to leverage the BDI team’s know-how in the development of next generation vaccines and drugs. Additionally, Dyadic will utilize BDI’s previous C1 industrial fermentation scale-up and commercialization experience with yeast and filamentous fungi processes to further advance Dyadic’s proprietary C1 technology for biopharmaceutical product development and production.
Florida Atlantic University’s new workforce training partnership with Sancilio & Company (SCI), a Riviera Beach-based biotech company, has yielded new careers for three recent graduates. SCI’s Daneish Patterson ‘17, human resources administrator; Alexander Haddad ‘17, scientist; and Courtney Cocilova ‘17, senior scientist; were among the first to enroll in FAU’s graduate-level course that is led by SCI scientists and focused on biopharmaceuticals and drug development.
A team of scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded nearly $2 million from the National Institute of Mental Health of the National Institutes of Health to develop an ‘industrial level’ high throughput screening platform that could lead to new treatments for a number of childhood brain disorders.